Reported Earnings • May 31
Full year 2026 earnings released: ₹4.19 loss per share (vs ₹2.31 loss in FY 2025) Full year 2026 results: ₹4.19 loss per share (further deteriorated from ₹2.31 loss in FY 2025). Revenue: ₹109.0m (down 30% from FY 2025). Net loss: ₹18.0m (loss widened 82% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year. Announcement • May 22
Phyto Chem (India) Limited to Report Q4, 2026 Results on May 29, 2026 Phyto Chem (India) Limited announced that they will report Q4, 2026 results on May 29, 2026 Buy Or Sell Opportunity • Apr 29
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.7% to ₹24.00. The fair value is estimated to be ₹30.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making. New Risk • Mar 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 53% per year over the past 5 years. Market cap is less than US$10m (₹100.4m market cap, or US$1.07m). Minor Risk Revenue is less than US$5m (₹118m revenue, or US$1.3m). Buy Or Sell Opportunity • Mar 19
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to ₹24.44. The fair value is estimated to be ₹30.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Mar 04
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 20% to ₹22.94. The fair value is estimated to be ₹29.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Feb 18
Third quarter 2026 earnings released: ₹1.13 loss per share (vs ₹3.54 profit in 3Q 2025) Third quarter 2026 results: ₹1.13 loss per share (down from ₹3.54 profit in 3Q 2025). Revenue: ₹32.8m (down 41% from 3Q 2025). Net loss: ₹4.85m (down 132% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Announcement • Feb 06
Phyto Chem (India) Limited to Report Q3, 2026 Results on Feb 14, 2026 Phyto Chem (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026 New Risk • Dec 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 54% per year over the past 5 years. Market cap is less than US$10m (₹134.5m market cap, or US$1.50m). Minor Risk Revenue is less than US$5m (₹125m revenue, or US$1.4m). Announcement • Nov 08
Phyto Chem (India) Limited to Report Q2, 2026 Results on Nov 14, 2025 Phyto Chem (India) Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Announcement • Sep 05
Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025 Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025, at 12:15 Indian Standard Time. Location: survey no.628, temple street, bonthapally - 502313, gummadidala mandal, sangareddy dist, telangana, India Announcement • Aug 02
Phyto Chem (India) Limited to Report Q1, 2026 Results on Aug 11, 2025 Phyto Chem (India) Limited announced that they will report Q1, 2026 results on Aug 11, 2025 New Risk • Jul 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.4x net interest cover). Share price has been highly volatile over the past 3 months (8.3% average weekly change). Earnings have declined by 68% per year over the past 5 years. Market cap is less than US$10m (₹122.3m market cap, or US$1.41m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m). New Risk • Jul 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (₹125.5m market cap, or US$1.46m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m). Reported Earnings • May 28
Full year 2025 earnings released: ₹2.31 loss per share (vs ₹7.75 loss in FY 2024) Full year 2025 results: ₹2.31 loss per share (improved from ₹7.75 loss in FY 2024). Revenue: ₹165.5m (down 1.5% from FY 2024). Net loss: ₹9.92m (loss narrowed 70% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance. Announcement • Apr 01
Phyto Chem (India) Limited Appoints Venkata Satish Babu Turlapati as Company Secretary and Compliance Officer, Effective March 31, 2025 Phyto Chem (India) Limited at its Boards of Directors meeting held on March 31, 2025, approved the appointment of Mr. Venkata Satish Babu Turlapati Company Secretary and Compliance Officer of the Company, effective March 31, 2025. Mr. Venkata Satish Babu Turlapati is a Fellow Member of the Institute of Company Secretaries of India (ICSI). He holds Degrees in Law and Commerce. With over three decades of experience, he has worked across listed and unlisted entities, specializing in corporate compliance, secretarial functions, and regulatory affairs under the Companies Act and SEBI regulations. He has a diverse professional background with expertise in the field of Secretarial and Legal matters. Mr. Venkata Satish Babu Turlapati is not related to any Director or KMP of the Company. Reported Earnings • Nov 16
Second quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.37 loss in 2Q 2024) Second quarter 2025 results: EPS: ₹0.26 (up from ₹0.37 loss in 2Q 2024). Revenue: ₹43.8m (down 39% from 2Q 2024). Net income: ₹1.11m (up ₹2.72m from 2Q 2024). Profit margin: 2.5% (up from net loss in 2Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance. New Risk • Sep 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Earnings have declined by 72% per year over the past 5 years. Market cap is less than US$10m (₹137.6m market cap, or US$1.65m). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (₹188m revenue, or US$2.2m). Announcement • Sep 05
Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024 Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:45 Indian Standard Time. Location: survey no. 628, temple street, gummadidala mandal, sangareddy district, bonthapally - 502313, telangana., bonthapally India Reported Earnings • Aug 15
First quarter 2025 earnings released: ₹3.41 loss per share (vs ₹4.08 loss in 1Q 2024) First quarter 2025 results: ₹3.41 loss per share (improved from ₹4.08 loss in 1Q 2024). Revenue: ₹46.2m (up ₹39.7m from 1Q 2024). Net loss: ₹14.7m (loss narrowed 16% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 129 percentage points per year, which is a significant difference in performance. Announcement • Aug 04
Phyto Chem (India) Limited to Report Q1, 2025 Results on Aug 12, 2024 Phyto Chem (India) Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Reported Earnings • Jun 04
Full year 2024 earnings released: ₹7.75 loss per share (vs ₹0.52 profit in FY 2023) Full year 2024 results: ₹7.75 loss per share (down from ₹0.52 profit in FY 2023). Revenue: ₹171.3m (down 36% from FY 2023). Net loss: ₹33.3m (down ₹35.5m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance. Announcement • May 22
Phyto Chem (India) Limited to Report Q4, 2024 Results on May 29, 2024 Phyto Chem (India) Limited announced that they will report Q4, 2024 results on May 29, 2024 Reported Earnings • Feb 13
Third quarter 2024 earnings released: EPS: ₹0.68 (vs ₹0.72 loss in 3Q 2023) Third quarter 2024 results: EPS: ₹0.68 (up from ₹0.72 loss in 3Q 2023). Revenue: ₹65.8m (down 17% from 3Q 2023). Net income: ₹2.93m (up ₹6.02m from 3Q 2023). Profit margin: 4.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance. Announcement • Feb 03
Phyto Chem (India) Limited to Report Q3, 2024 Results on Feb 12, 2024 Phyto Chem (India) Limited announced that they will report Q3, 2024 results on Feb 12, 2024 Reported Earnings • Nov 03
Second quarter 2024 earnings released: ₹0.37 loss per share (vs ₹4.60 profit in 2Q 2023) Second quarter 2024 results: ₹0.37 loss per share (down from ₹4.60 profit in 2Q 2023). Revenue: ₹72.1m (down 42% from 2Q 2023). Net loss: ₹1.60m (down 108% from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance. Announcement • Aug 10
Phyto Chem (India) Limited Approves Appointment of N. Nagendra Naidu as Non-Executive Independent Director Phyto Chem (India) Limited at the Annual General meeting held on August 7, 2023, approved appointment of Mr. N. Nagendra Naidu (DIN: 10180163) as a Non-Executive Independent Director of the Company. New Risk • Aug 08
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (₹165.9m market cap, or US$2.00m). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Revenue is less than US$5m (₹262m revenue, or US$3.2m). Announcement • Jul 29
Phyto Chem (India) Limited to Report Q1, 2024 Results on Aug 07, 2023 Phyto Chem (India) Limited announced that they will report Q1, 2024 results on Aug 07, 2023 Reported Earnings • Jul 15
Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022) Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹267.6m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Jul 14
Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023 Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023, at 11:30 Indian Standard Time. Location: Survey No.628, Temple Street, Bonthapally - 502 313 Gummadidala Mandal, Sangareddy District, Telangana State Sangareddy India Agenda: To consider and approve the Audited Financial Statements of the Company as at 31 March 2023, along with the Reports of the Board of Directors and Auditors thereon; to consider and approve the appointment of a Director in place of Mr. Anjaneyulu Prathipati who retires by rotation and being eligible, offers himself for reappointment; and to consider other matters. Valuation Update With 7 Day Price Move • Jun 12
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹38.44, the stock trades at a trailing P/E ratio of 74.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022) Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹269.2m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • May 06
Phyto Chem (India) Limited Announces Resignation of K.Ravindra Babu as an Independent Director, Effective from May 12, 2023 Phyto Chem (India) Limited announced that Mr. K.Ravindra Babu has resigned from the position of the independent director of the company with effect from May 12, 2023. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to ₹27.14, the stock trades at a trailing P/E ratio of 78.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years. Reported Earnings • Feb 16
Third quarter 2023 earnings released: ₹0.72 loss per share (vs ₹1.21 profit in 3Q 2022) Third quarter 2023 results: ₹0.72 loss per share (down from ₹1.21 profit in 3Q 2022). Revenue: ₹79.4m (up 4.1% from 3Q 2022). Net loss: ₹3.09m (down 160% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings. Announcement • Feb 07
Phyto Chem (India) Limited to Report Q3, 2023 Results on Feb 14, 2023 Phyto Chem (India) Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 14, 2023 Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹61.95, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 169% over the past three years. Valuation Update With 7 Day Price Move • Jan 16
Investor sentiment improved over the past week After last week's 17% share price gain to ₹67.50, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 170% over the past three years. Valuation Update With 7 Day Price Move • Jan 02
Investor sentiment improved over the past week After last week's 15% share price gain to ₹50.15, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 116% over the past three years. Valuation Update With 7 Day Price Move • Dec 14
Investor sentiment improved over the past week After last week's 16% share price gain to ₹35.85, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 78% over the past three years. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improved over the past week After last week's 21% share price gain to ₹34.40, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 47% over the past three years. Announcement • Oct 23
Phyto Chem (India) Limited to Report Q2, 2023 Results on Oct 31, 2022 Phyto Chem (India) Limited announced that they will report Q2, 2023 results at 2:30 PM, Indian Standard Time on Oct 31, 2022 Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improved over the past week After last week's 25% share price gain to ₹20.60, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years. Announcement • Sep 06
Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022 Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022, at 11:45 Indian Standard Time. Location: Registered Office at Survey No. 628, Temple Street, Bonthapally Gummadidala Mandal Sangareddy India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company as at 31% March 2022, along with the Reports of the Board of Directors and Auditors thereon; to consider directorate reelections; and to consider other matters. Reported Earnings • Aug 10
First quarter 2023 earnings released: ₹3.65 loss per share (vs ₹3.38 loss in 1Q 2022) First quarter 2023 results: ₹3.65 loss per share (down from ₹3.38 loss in 1Q 2022). Revenue: ₹14.1m (down 16% from 1Q 2022). Net loss: ₹15.7m (loss widened 8.0% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.21 (up from ₹0.94 in 3Q 2021). Revenue: ₹76.7m (up 31% from 3Q 2021). Net income: ₹5.18m (up 29% from 3Q 2021). Profit margin: 6.8% (down from 6.9% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 04
Full year 2021 earnings released: EPS ₹1.15 (vs ₹1.04 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹452.9m (up 2.4% from FY 2020). Net income: ₹4.93m (up 11% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 17% share price gain to ₹26.80, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years. Is New 90 Day High Low • Feb 22
New 90-day low: ₹20.60 The company is down 8.0% from its price of ₹22.35 on 24 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Feb 13
Third quarter 2021 earnings released: EPS ₹0.94 (vs ₹0.73 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹61.0m (down 65% from 3Q 2020). Net income: ₹4.03m (up 28% from 3Q 2020). Profit margin: 6.6% (up from 1.8% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year whereas the company’s share price has fallen by 26% per year. Announcement • Feb 05
Phyto Chem (India) Limited to Report Q3, 2021 Results on Feb 12, 2021 Phyto Chem (India) Limited announced that they will report Q3, 2021 results on Feb 12, 2021 Is New 90 Day High Low • Jan 04
New 90-day high: ₹27.85 The company is up 7.0% from its price of ₹26.15 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 18% share price gain to ₹25.65, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.9x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 66%. Announcement • Dec 06
Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020 Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020, at 11:45 Indian Standard Time. Location: Survey No.628, Tem ple Street Bonthapally - 502 313, Gummadidala Mandal Sangareddy Andhra Pradesh India Agenda: To consider and adopt the Audited Balance Sheet as at March 31, 2020, Profit and Loss Account and Cash Flow Statement for the year ended on that date along with the Reports of the Board of Directors and Auditors thereon; to consider the re-appointment of Mr. Anjaneyulu Prathipati as Director; to consider the re-appointment of Dr. G.S.R.Anjaneyulu as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Ravindra Babu Kakarla as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Yugandhar Sampath Kumar Sakhamuri as a Non-Executive Independent Director of the Company; to consider the appointment of Mrs. Vijitha Gorrepati as a Woman Non-Executive Independent Director of the Company; and to consider the Continuation of Directorship of Dr. Venkateswarlu Yadlapalli as a Non- Executive Non-Independent Director. Reported Earnings • Nov 16
Second quarter 2021 earnings released: EPS ₹2.91 The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹177.1m (down 15% from 2Q 2020). Net income: ₹12.5m (down 19% from 2Q 2020). Profit margin: 7.1% (down from 7.4% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Announcement • Nov 13
Phyto Chem (India) Limited Announces Cessation of Independent Directors Phyto Chem (India) Limited announced that Mr. N. Sudhakar, Mr. T. A. Choudary and Mrs. S. Kavitha Rani as the cessation of independent directors effect from November 12, 2020. Valuation Update With 7 Day Price Move • Oct 28
Market bids up stock over the past week After last week's 17% share price gain to ₹23.95, the stock is trading at a trailing P/E ratio of 13.8x, up from the previous P/E ratio of 11.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 62%. Valuation Update With 7 Day Price Move • Oct 14
Market pulls back on stock over the past week After last week's 15% share price decline to ₹22.05, the stock is trading at a trailing P/E ratio of 12.7x, down from the previous P/E ratio of 15x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 65%. Is New 90 Day High Low • Sep 18
New 90-day low: ₹21.85 The company is down 22% from its price of ₹28.00 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Announcement • Sep 08
Phyto Chem (India) Limited to Report Q1, 2021 Results on Sep 14, 2020 Phyto Chem (India) Limited announced that they will report Q1, 2021 results on Sep 14, 2020 
